HSP‐enriched properties of extracellular vesicles involve survival of metastatic oral cancer cells

Cancer cells often secrete extracellular vesicles (EVs) that carry heat shock proteins (HSPs) with roles in tumor progression. Oral squamous cell carcinoma (OSCC) belongs to head and neck cancers (HNC) whose lymph‐node‐metastases often lead to poor prognosis. We have examined the EV proteome of OSCC...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cellular biochemistry 2018-09, Vol.119 (9), p.7350-7362
Hauptverfasser: Ono, Kisho, Eguchi, Takanori, Sogawa, Chiharu, Calderwood, Stuart K., Futagawa, Junya, Kasai, Tomonari, Seno, Masaharu, Okamoto, Kuniaki, Sasaki, Akira, Kozaki, Ken‐ichi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Cancer cells often secrete extracellular vesicles (EVs) that carry heat shock proteins (HSPs) with roles in tumor progression. Oral squamous cell carcinoma (OSCC) belongs to head and neck cancers (HNC) whose lymph‐node‐metastases often lead to poor prognosis. We have examined the EV proteome of OSCC cells and found abundant secretion of HSP90‐enriched EVs in lymph‐node‐metastatic OSCC cells. Double knockdown of HSP90α and HSP90β, using small interfering RNA significantly reduced the survival of the metastatic OSCC cells, although single knockdown of each HSP90 was ineffective. Elevated expression of these HSP90 family members was found to correlate with poor prognosis of HNC cases. Thus, elevated HSP90 levels in secreted vesicles are potential prognostic biomarkers and therapeutic targets in metastatic OSCC. Cancer cells often secrete extracellular vesicles (EVs) that carry heat shock proteins (HSPs) with roles in tumor progression. Lymph‐node‐metastases of oral squamous cell carcinoma (OSCC) often lead to poor prognosis. Elevated HSP90 levels in secreted vesicles are potential prognostic biomarkers and therapeutic targets in metastatic OSCC.
ISSN:0730-2312
1097-4644
DOI:10.1002/jcb.27039